NIG
JAZZ icon

NFJ Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

NFJ Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,376
Closed -$2.82M – 263
2025
Q3 		$2.82M Sell
21,376
-2,489
-10% -$299K 0.1% 153
2025
Q2 		$2.53M Sell
23,865
-158
-0.7% -$17.2K 0.09% 188
2025
Q1 		$2.98M Buy
+24,023
New +$3.13M 0.1% 164

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

NFJ Investment Group's JAZZ Position: Q4 2025 in Review

NFJ Investment Group sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2025, closing a stake of 21,376 shares — an estimated $2.82M sold.

NFJ Investment Group first reported a position in JAZZ in Q1 2025 and held it in 3 quarters. The position peaked at $2.98M in Q1 2025. 576 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • NFJ Investment Group reported no remaining Jazz Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • NFJ Investment Group sold 21,376 Jazz Pharmaceuticals shares in Q4 2025, an estimated $2.82M.
  • NFJ Investment Group first reported a position in Jazz Pharmaceuticals in Q1 2025 and held it in 3 quarters.
  • NFJ Investment Group's Jazz Pharmaceuticals position peaked at $2.98M in Q1 2025.
  • 576 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on NFJ Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.